Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age

Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age

Abstract Background Statins have been recommended by several guidelines as the primary prevention medication for cardiovascular diseases. However, the benefits of statin therapy for cerebral small vessel disease (CSVD), particularly in adults ≥75 years of age, have not been fully evaluated. Methods...

Full description

Bibliographic Details
Main Authors: Yuqi Guo, Yunpeng Li, Xukui Liu, Yi Cui, Yingxin Zhao, Shangwen Sun, Qing Jia, Qiang Chai, Gary Gong, Hua Zhang, Zhendong Liu
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Geriatrics
Subjects:
Statins
Neuroprotection
Cerebral small vessel disease
Aging
Online Access:http://link.springer.com/article/10.1186/s12877-020-01682-w

Similar Items

Similar Items